Journal Information
Vol. 80. Issue 6.
Pages 348-356 (01 June 2014)
Vol. 80. Issue 6.
Pages 348-356 (01 June 2014)
Full text access
Morbidity and mortality in newborns at the limit of viability in Spain: A population-based study
Morbimortalidad en recién nacidos al límite de la viabilidad en España: estudio de base poblacional
F. García-Muñoz Rodrigoa,��
Corresponding author

Corresponding author.
, A. García-Alix Pérezb, J.A. García Hernándezc, J. Figueras Aloyd, Grupo Sen1500
a Servicio de Neonatología, Complejo Hospitalario Universitario Insular Materno-Infantil de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
b Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain
c Servicio de Ginecología y Obstetricia, Complejo Hospitalario Universitario Insular Materno-Infantil de Las Palmas de Gran Canaria, Las Palmas de Gran Canaria, Spain
d Hospital Clínic, Barcelona, Spain
Article information
Download PDF

Perinatal care in extremely immature newborns is a clinical and ethical problem of great importance for professionals and families, and requires that the available information on the chances of child survival is of the highest quality. The aim of this study was to determine the specific rates of survival at hospital discharge, and survival without major morbidity in newborns with a gestation age (GA) ≤ 26 weeks in Spain.

Patients and methods

We included live newborns ≤ 26 weeks admitted to the collaborating centres of the SEN1500 network (2004-2010). Outborn patients, infants who died in delivery room, and those with congenital anomalies incompatible with life were excluded.


A total of 3,236 patients were included. GA specific survival was 12.5, 13.1, 36.9, 55.7, and 71.9% at 22, 23, 24, 25, and 26 weeks of GA, respectively. Survival without severe intracranial haemorrhage, periventricular leukomalacia, bronchopulmonary dysplasia, and/or retinopathy of prematurity was 1.5, 9.5, 19.0, and 29.9% at 23, 24, 25 and 26 weeks GA, respectively.


Survival without major morbidity in infants less than 23 weeks GA is exceptional, and scarce in newborns with 23 and 24 weeks GA. Infants ≥ 25 weeks GA have reasonable chances of survival and, in the absence of major malformations or other relevant complications, they should be offered active resuscitation and intensive care. The continuous updating of the results of individual centres is of utmost importance, as well as their comparison with the reference population-based results.

Limits of viability
Extreme prematurity
Major brain damage
Clinical decision- making

La asistencia perinatal a recién nacidos (RN) extremadamente inmaduros constituye un problema clínico y ético de gran trascendencia para profesionales y familias, y hace necesaria una información actualizada de la máxima calidad acerca de las posibilidades de supervivencia del niño. El objetivo de este estudio fue conocer las tasas específicas de supervivencia al alta hospitalaria y de supervivencia sin morbilidad mayor conocida en RN con una edad gestacional (EG) ≤ 26 semanas en España.

Pacientes y métodos

Se incluyeron los RN vivos de ≤ 26 semanas que ingresaron en los centros colaboradores de la red SEN1500 (2004-2010). Se excluyeron los nacidos extramuros, los fallecidos en el paritorio y los que tenían malformaciones incompatibles con la vida.


En total 3.236 pacientes fueron incluidos. La supervivencia específica por EG fue de 12,5, 13,1, 36,9, 55,7 y 71,9% a las 22, 23, 24, 25 y 26 semanas de EG, respectivamente. La supervivencia sin hemorragia intracraneal grave, leucomalacia periventricular, displasia broncopulmonar y/o retinopatía de la prematuridad fue del 1,5, 9,5, 19,0 y 29,9% a las 23, 24, 25 y 26 semanas, respectivamente.


La supervivencia sin morbilidad mayor en menores de 23 semanas de EG es excepcional, y en RN de 23 y 24 semanas, muy baja. Los RN ≥ 25 semanas de EG tienen posibilidades razonables de supervivencia y, en ausencia de malformaciones mayores u otras complicaciones relevantes, se les debería ofrecer reanimación activa y cuidados intensivos. Es fundamental la actualización continua de los datos propios de cada centro y su comparación con los resultados poblacionales de referencia.

Palabras clave:
Límites de viabilidad
Prematuridad extrema
Lesión cerebral mayor
Toma de decisiones clínicas
Full text is only aviable in PDF
N.S. Wood, N. Marlow, K. Costeloe, B. Chir, A.T. Gibson, A.R. Wilkinson.
The EPICure Study Group. Neurologic and developmental disability after extremely preterm birth.
N Engl J Med., 343 (2000), pp. 378-384
L.W. Doyle, G. Roberts, P.J. Anderson.
Outcomes at age 2 years of infants < 28 weeks’ gestational age born in Victoria in 2005.
J Pediatr., 156 (2010), pp. 49-53
J.E. Tyson, N.A. Parikh, J. Langer, C. Green, R.D. Higgins.
The National Institute of Child Health and Human Development Neonatal Research Network Intensive care for extreme prematurity Moving beyond gestational age.
N Engl J Med., 358 (2008), pp. 1672-1681
C.E. Mercier, M.S. Dunn, K.R. Ferrelli, D.B. Howard, R.F. Soll.
Neurodevelopmental outcome of extremely low birth weight infants from the Vermont Oxford Network: 1998-2003.
Neonatology., 97 (2010), pp. 329-338
B.J. Stoll, N.I. Hansen, E.F. Bell, S. Shankaran, A.R. Laptook, M.C. Walsh, et al.
Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network.
Pediatrics., 126 (2010), pp. 443-456
Fischer N, Steurer MA, Adams M, Berger TM. Survival rates of extremely preterm infants (gestational age < 26 weeks) in Switzerland: Impact of the Swiss guidelines for the care of infants born at the limit of viability. Arch Dis Child Fetal Neonatal Ed. 2009; 94:F407-F413.
M. Moro Serrano, C. Fernández Pérez, J. Figueras Alloy, J. Pérez Rodríguez, E. Coll, E. Doménech Martínez, et al.
Diseño y desarrollo del registro de niños de menos de 1.500 g al nacer en España.
An Pediatr (Barc)., 68 (2008), pp. 181-188
L.A. Papile, J. Burstein, R. Burstein, H. Koffler.
Incidence and evolution of subependymal and intraventricular hemorrhage: A study of infants with birth weights less than 1,500 gm.
J Pediatr., 92 (1978), pp. 529-534
M.J. Bell, J.L. Ternberg, R.D. Feigin, J.P. Keating, R. Marshall, L. Barton, et al.
Neonatal necrotizing enterocolitis: Therapeutic decisions based upon clinical staging.
Ann Surg., 187 (1978), pp. 1-7
International Committee for the Classification of Retinopathy of Prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol. 2005; 123:991-9.
IBM® SPSS® Statistics 19. Copyright IBM Corporation 2010. IBM Corporation, Route 100 Somers, NY 10589.
The International Neonatal Network. The CRIB (Clinical Risk Index for Babies) score: A tool for assessing initial neonatal risk and comparing performance of neonatal intensive care units. Lancet. 1993; 342:193-8.
P. Vanhaesebrouck, K. Allegaert, J. Bottu, C. Debauche, H. Devlieger, M. Docx, et al.
The EPIBEL study: Outcomes to discharge from hospital for extremely preterm infants in Belgium.
Pediatrics., 114 (2004), pp. 663-675
K. Costeloe, E. Hennessy, A.T. Gibson, N. Marlow, A.R. Wilkinson.
The EPICure Study: Outcomes to discharge from hospital for infants born at the threshold of viability.
Pediatrics., 106 (2000), pp. 659-671
B. Larroque, G. Bréart, M. Kaminski, M. Dehan, M. André, A. Burguet, et al.
on behalf of the Epipage study Group Survival of very preterm infants: Epipage, a population based cohort study.
Arch Dis Child Fetal Neonatal Ed., 89 (2004), pp. F139-F144
T.B. Ferrara, R.E. Hoekstra, R.J. Couser, E.P. Gaziano, S.E. Calvin, N.R. Payne, et al.
Survival and follow-up of infants born at 23 to 26 weeks of gestational age: Effects of surfactant therapy.
J Pediatr., 124 (1994), pp. 119-124
D. El-Metwally, B. Vohr, R. Tucker.
Survival and neonatal morbidity at the limits of viability in the mid 1990s: 22 to 25 weeks.
J Pediatr., 137 (2000), pp. 616-622
R.F. Soll.
Prophylactic natural surfactant extract for preventing morbidity and mortality in preterm infants.
Cochrane Database Syst Rev., 2 (2000), pp. CD000511
J.D. Horbar, J.H. Carpenter, G.J. Badger, M.J. Kenny, R.F. Soll, K.A. Morrow, et al.
Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009.
Pediatrics., 129 (2012), pp. 1019-1026
R.H. Pfister, R.F. Soll.
Initial respiratory support of preterm infants The role of CPAP, the INSURE method, and noninvasive ventilation.
Clin Perinatol., 39 (2012), pp. 459-481
D.G. Sweet, V. Carnielli, G. Greisen, M. Hallman, E. Ozek, R. Plavka, et al.
European consensus guidelines on the management of neonatal respiratory distress syndrome in preterm infants 2013 update.
Neonatology., 103 (2013), pp. 353-368
Costeloe KL, Hennessy EM, Haider S, Stacey F, Marlow N, Draper ES. Short term outcomes after extreme preterm birth in England: Comparison of two birth cohorts in 1995 and 2006 (the EPICure studies). BMJ. 2012; 345:e7976.
T.M. Luu, L.R. Ment, K.C. Schneider, K.H. Katz, W.C. Allan, B.R. Vohr.
Lasting effects of preterm birth and neonatal brain hemorrhage at 12 years of age.
Pediatrics., 123 (2009), pp. 1037-1044
A. Farooqi, B. Hägglöf, G. Sedin, F. Serenius.
Impact at age 11 years of major neonatal morbidities in children born extremely preterm.
Pediatrics., 127 (2011), pp. e1247-e1257
A.R. O’Connor, T. Stephenson, A. Johnson, M.J. Tobin, M.J. Moseley, S. Ratib, et al.
Long-term ophthalmic outcome of low birth weight children with and without retinopathy of prematurity.
Pediatrics., 109 (2002), pp. 12-18
M.E. Msall, D.L. Phelps, K.M. DiGaudio, V. Dobson, B. Tung, R.E. McClead, et al.
Severity of neonatal retinopathy of prematurity is predictive of neurodevelopmental functional outcome at age 5.5 years.
Behalf of the Cryotherapy for Retinopathy of Prematurity Cooperative Group. Pediatrics., 106 (2000), pp. 998-1005
R.C. Holman, B.J. Stoll, A.T. Curns, K.L. Yorita, C.A. Steiner, L.B. Schonberger.
Necrotising enterocolitis hospitalisations among neonates in the United States.
Paediatr Perinat Epidemiol., 20 (2006), pp. 498-506

Please cite this article as: García-Muñoz Rodrigo F, García-Alix Pérez A, García Hernández JA, Figueras Aloy J, Grupo SEN1500. Morbimortalidad en recién nacidos al límite de la viabilidad en España: estudio de base poblacional. An Pediatr (Barc). 2014;80:348-356.

Copyright © 2013. Asociación Española de Pediatría
Anales de Pediatría (English Edition)

Subscribe to our newsletter

Article options
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?